ReP USP - Resultado da busca

Artigo de periodico
Protective immunity and reduced renal colonization induced by vaccines containing recombinant Leptospira interrogans outer membrane proteins and flagellin adjuvant (2015)
Monaris, Denize; Sbrogio-Almeida, Maria Elisabete; Dib, Cristina Corsi; Canhamero, T. A; Souza, G. O; Vasconcellos, Silvio Arruda; Ferreira, Luís Carlos de Souza ; Abreu, Patricia Antonia Estima
Source: Clinical and Vaccine Immunology. Unidades: FMVZ, ICB
Subjects: LEPTOSPIROSE, LEPTOSPIROSE ANIMAL, VACINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MONARIS, Denize et al. Protective immunity and reduced renal colonization induced by vaccines containing recombinant Leptospira interrogans outer membrane proteins and flagellin adjuvant. Clinical and Vaccine Immunology, v. 22, n. 8, p. 965-973, 2015Tradução . . Disponível em: https://doi.org/10.1128/CVI.00285-15. Acesso em: 25 ago. 2024.
APA
Monaris, D., Sbrogio-Almeida, M. E., Dib, C. C., Canhamero, T. A., Souza, G. O., Vasconcellos, S. A., et al. (2015). Protective immunity and reduced renal colonization induced by vaccines containing recombinant Leptospira interrogans outer membrane proteins and flagellin adjuvant. Clinical and Vaccine Immunology, 22( 8), 965-973. doi:10.1128/CVI.00285-15
NLM
Monaris D, Sbrogio-Almeida ME, Dib CC, Canhamero TA, Souza GO, Vasconcellos SA, Ferreira LC de S, Abreu PAE. Protective immunity and reduced renal colonization induced by vaccines containing recombinant Leptospira interrogans outer membrane proteins and flagellin adjuvant [Internet]. Clinical and Vaccine Immunology. 2015 ; 22( 8): 965-973.[citado 2024 ago. 25 ] Available from: https://doi.org/10.1128/CVI.00285-15
Vancouver
Monaris D, Sbrogio-Almeida ME, Dib CC, Canhamero TA, Souza GO, Vasconcellos SA, Ferreira LC de S, Abreu PAE. Protective immunity and reduced renal colonization induced by vaccines containing recombinant Leptospira interrogans outer membrane proteins and flagellin adjuvant [Internet]. Clinical and Vaccine Immunology. 2015 ; 22( 8): 965-973.[citado 2024 ago. 25 ] Available from: https://doi.org/10.1128/CVI.00285-15
Artigo de periodico
Adjuvant requirement for successful immunization with recombinant derivatives of Plasmodium vivax merozoite surface protein-1 delivered via the intranasal route (2007)
Bargieri, Daniel Youssef ; Rosa, Daniela Santoro; Lasaro, Melissa Ang Simões; Ferreira, Luís Carlos de Souza ; Soares, Irene da Silva ; Rodrigues, Mauricio Martins
Source: Memórias do Instituto Oswaldo Cruz. Unidades: ICB, FCF
Subjects: PLASMODIUM, VACINAS, ADJUVANTES IMUNOLÓGICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BARGIERI, Daniel Youssef et al. Adjuvant requirement for successful immunization with recombinant derivatives of Plasmodium vivax merozoite surface protein-1 delivered via the intranasal route. Memórias do Instituto Oswaldo Cruz, v. 102, n. 3, p. 313-317, 2007Tradução . . Disponível em: https://doi.org/10.1590/s0074-02762007005000039. Acesso em: 25 ago. 2024.
APA
Bargieri, D. Y., Rosa, D. S., Lasaro, M. A. S., Ferreira, L. C. de S., Soares, I. da S., & Rodrigues, M. M. (2007). Adjuvant requirement for successful immunization with recombinant derivatives of Plasmodium vivax merozoite surface protein-1 delivered via the intranasal route. Memórias do Instituto Oswaldo Cruz, 102( 3), 313-317. doi:10.1590/s0074-02762007005000039
NLM
Bargieri DY, Rosa DS, Lasaro MAS, Ferreira LC de S, Soares I da S, Rodrigues MM. Adjuvant requirement for successful immunization with recombinant derivatives of Plasmodium vivax merozoite surface protein-1 delivered via the intranasal route [Internet]. Memórias do Instituto Oswaldo Cruz. 2007 ; 102( 3): 313-317.[citado 2024 ago. 25 ] Available from: https://doi.org/10.1590/s0074-02762007005000039
Vancouver
Bargieri DY, Rosa DS, Lasaro MAS, Ferreira LC de S, Soares I da S, Rodrigues MM. Adjuvant requirement for successful immunization with recombinant derivatives of Plasmodium vivax merozoite surface protein-1 delivered via the intranasal route [Internet]. Memórias do Instituto Oswaldo Cruz. 2007 ; 102( 3): 313-317.[citado 2024 ago. 25 ] Available from: https://doi.org/10.1590/s0074-02762007005000039
Artigo de periodico
Anti-tumor DNA vaccines based on the expression of human papillomavirus-16 E6/E7 oncoproteins genetically fused with the glycoprotein D from herpes simplex virus-1 (2005)
Lasaro, Marcio O.; Diniz, Mariana O.; Reyes-Sandoval, Arturo; Ertl, Hildegund C.; Ferreira, Luís Carlos de Souza
Source: Microbes and infection. Unidade: ICB
Assunto: MICROBIOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LASARO, Marcio O. et al. Anti-tumor DNA vaccines based on the expression of human papillomavirus-16 E6/E7 oncoproteins genetically fused with the glycoprotein D from herpes simplex virus-1. Microbes and infection, v. 7, p. 1541-1550, 2005Tradução . . Disponível em: https://doi.org/10.1016/j.micinf.2005.05.024. Acesso em: 25 ago. 2024.
APA
Lasaro, M. O., Diniz, M. O., Reyes-Sandoval, A., Ertl, H. C., & Ferreira, L. C. de S. (2005). Anti-tumor DNA vaccines based on the expression of human papillomavirus-16 E6/E7 oncoproteins genetically fused with the glycoprotein D from herpes simplex virus-1. Microbes and infection, 7, 1541-1550. doi:10.1016/j.micinf.2005.05.024
NLM
Lasaro MO, Diniz MO, Reyes-Sandoval A, Ertl HC, Ferreira LC de S. Anti-tumor DNA vaccines based on the expression of human papillomavirus-16 E6/E7 oncoproteins genetically fused with the glycoprotein D from herpes simplex virus-1 [Internet]. Microbes and infection. 2005 ; 7 1541-1550.[citado 2024 ago. 25 ] Available from: https://doi.org/10.1016/j.micinf.2005.05.024
Vancouver
Lasaro MO, Diniz MO, Reyes-Sandoval A, Ertl HC, Ferreira LC de S. Anti-tumor DNA vaccines based on the expression of human papillomavirus-16 E6/E7 oncoproteins genetically fused with the glycoprotein D from herpes simplex virus-1 [Internet]. Microbes and infection. 2005 ; 7 1541-1550.[citado 2024 ago. 25 ] Available from: https://doi.org/10.1016/j.micinf.2005.05.024
Artigo de periodico
Prime-boost vaccine regimen confers protective immunity to human-derived enterotoxigenic Escherichia coli (2005)
Lasaro, M. O.; Luiz, W. B.; Sbrogio-Almeida, M. E.; Ferreira, Luís Carlos de Souza
Source: Vaccine. Unidade: ICB
Assunto: MICROBIOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LASARO, M. O. et al. Prime-boost vaccine regimen confers protective immunity to human-derived enterotoxigenic Escherichia coli. Vaccine, v. 23, p. 2430-2438, 2005Tradução . . Disponível em: https://doi.org/10.1016/j.vaccine.2004.11.026. Acesso em: 25 ago. 2024.
APA
Lasaro, M. O., Luiz, W. B., Sbrogio-Almeida, M. E., & Ferreira, L. C. de S. (2005). Prime-boost vaccine regimen confers protective immunity to human-derived enterotoxigenic Escherichia coli. Vaccine, 23, 2430-2438. doi:10.1016/j.vaccine.2004.11.026
NLM
Lasaro MO, Luiz WB, Sbrogio-Almeida ME, Ferreira LC de S. Prime-boost vaccine regimen confers protective immunity to human-derived enterotoxigenic Escherichia coli [Internet]. Vaccine. 2005 ; 23 2430-2438.[citado 2024 ago. 25 ] Available from: https://doi.org/10.1016/j.vaccine.2004.11.026
Vancouver
Lasaro MO, Luiz WB, Sbrogio-Almeida ME, Ferreira LC de S. Prime-boost vaccine regimen confers protective immunity to human-derived enterotoxigenic Escherichia coli [Internet]. Vaccine. 2005 ; 23 2430-2438.[citado 2024 ago. 25 ] Available from: https://doi.org/10.1016/j.vaccine.2004.11.026
Artigo de periodico
Bacillus subtilis as a tool for vaccine development: from antigen factories to delivery vectors (2005)
Ferreira, Luís Carlos de Souza ; Ferreira, Rita de Cássia Café ; Schumann, Wolfgang
Source: Anais da Academia Brasileira de Ciências. Unidade: ICB
Assunto: MICROBIOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERREIRA, Luís Carlos de Souza e FERREIRA, Rita de Cássia Café e SCHUMANN, Wolfgang. Bacillus subtilis as a tool for vaccine development: from antigen factories to delivery vectors. Anais da Academia Brasileira de Ciências, v. 77, n. 1, p. 113-124, 2005Tradução . . Disponível em: https://doi.org/10.1590/s0001-37652005000100009. Acesso em: 25 ago. 2024.
APA
Ferreira, L. C. de S., Ferreira, R. de C. C., & Schumann, W. (2005). Bacillus subtilis as a tool for vaccine development: from antigen factories to delivery vectors. Anais da Academia Brasileira de Ciências, 77( 1), 113-124. doi:10.1590/s0001-37652005000100009
NLM
Ferreira LC de S, Ferreira R de CC, Schumann W. Bacillus subtilis as a tool for vaccine development: from antigen factories to delivery vectors [Internet]. Anais da Academia Brasileira de Ciências. 2005 ; 77( 1): 113-124.[citado 2024 ago. 25 ] Available from: https://doi.org/10.1590/s0001-37652005000100009
Vancouver
Ferreira LC de S, Ferreira R de CC, Schumann W. Bacillus subtilis as a tool for vaccine development: from antigen factories to delivery vectors [Internet]. Anais da Academia Brasileira de Ciências. 2005 ; 77( 1): 113-124.[citado 2024 ago. 25 ] Available from: https://doi.org/10.1590/s0001-37652005000100009

USP Schools

ReP

Filtros

Authors

Subjects

Indexado em